CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Multi-Center Open-Label Clinical Trial to Assess the Prevention of Liver Transplantation and/or Death Among Subjects Treated With Intravenous Silibinin (Legalon® SIL) for Amatoxin Induced Hepatic Failure

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00915681
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:43.257267+00:00
Published At: 2022-04-07T00:00:00+00:00
Record Updated At: 2022-04-07
Results Posted At: 2022-04-07
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Amatoxin Poisoning", "Amanita Poisoning", "Mushroom Poisoning", "Liver Failure"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-04-07"
protocolSection.identificationModule.nctId: "NCT00915681"
protocolSection.identificationModule.officialTitle: "A Phase II Multi-Center Open-Label Clinical Trial to Assess the Prevention of Liver Transplantation and/or Death Among Subjects Treated With Intravenous Silibinin (Legalon\u00ae SIL) for Amatoxin Induced Hepatic Failure"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2022-04-07"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.